Open AccessDevelopment and Pre-Testing of a Rehabilitation Planning Consultation for Head-and-Neck Cancer
Author(s) -
Sara McEwen,
Colleen Dunphy,
Jorge Rios,
Aileen M. Davis,
Jennifer Jones,
Andrew C L Lam,
Ian Poon,
Rosemary Martino,
Jolie Ringash
Publication year - 2017
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.24.3529
Subject(s) - rehabilitation , medicine , head and neck cancer , physical therapy , intervention (counseling) , test (biology) , coping (psychology) , radiation treatment planning , cancer , physical medicine and rehabilitation , nursing , surgery , clinical psychology , radiation therapy , paleontology , biology
Background: In contrast with other major chronic conditions such as heart disease and stroke, cancer care does not routinely integrate evidence-based rehabilitation services within the standard continuum. The objectives of the present project were to develop a rehabilitation planning consultation (RPC) for survivors of head-and-neck (HN) cancer, to test its feasibility, and to make refinements. Methods: Using intervention mapping, the RPC-alpha was developed by examining potential theoretical methods and practical applications relative to the program objectives. During feasibility testing, a single case series was conducted with survivors of HN cancer who had completed their cancer treatment within the preceding 11 months; iterative refinements were made after each case. Results: The RPC-alpha was led by a rehabilitation professional and was based on self-management principles. The initial consultation included instruction in a global cognitive strategy, goal-setting, introduction to available resources, action planning, and coping planning. A follow-up consultation was conducted a few weeks later. Of 9 participants recruited, 5 completed post-intervention assessments. Participants reported that the rpc helped them to make rehabilitation plans. Conclusions: The rpc was feasible to use and satisfactory to a small group of hn cancer survivors. A pilot test of the refined version is in process.